Table 2 Clinical data of the patient.
From: A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma
Cell line | Patient age/ethicity | Gender | Current Status (days) | Histopathology/differentiation | Tumor size(cm) | Prior therapy | Culture date | Serum | ||
|---|---|---|---|---|---|---|---|---|---|---|
AFP IU/ml (0–5.8) | CEA ng/ml (0–5.2) | CA199 U/ml (0–35) | ||||||||
PDAC-X2 | 64/Asian | Female | Alive | Moderately-poorly | 5.5 × 2 | None | 2022–7-4 | 2.2 | 6.7 | > 1000 |
